Unión Europea - español - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Unión Europea - español - EMA (European Medicines Agency)

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - trastornos de iniciación y mantenimiento del sueño - psicolépticos - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

apotex europe b.v. - finasterida - comprimido recubierto con pelÍcula - 5 mg - finasterida 5 mg - finasterida

Unión Europea - español - EMA (European Medicines Agency)

n.v. organon - desloratadina - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamínicos para uso sistémico, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

b. braun melsungen ag - trigliceridos cadena media; aceite soja purificado; trigliceridos omega-3 - emulsiÓn para perfusiÓn - 100 mg/ml + 80 mg/ml + 20 mg/ml inyectable 500 ml - trigliceridos cadena media 100 mg; aceite soja purificado 80 mg; trigliceridos omega-3 20 mg - emulsiones grasas

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - drogas usadas en diabetes - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 y 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - acetato de abiraterona - neoplasmas prostáticos - terapia endocrina - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - acetato de abiraterona - neoplasmas prostáticos - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unión Europea - español - EMA (European Medicines Agency)

krka, d.d., novo mesto - acetato de abiraterona - neoplasmas prostáticos - terapia endocrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Unión Europea - español - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - insuficiencia cardíaca - antagonistas de angiotensina ii, otras combinaciones, agentes que actúan sobre el sistema renina-angiotensina - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.